SEC Form 4 · accession 0001306119-26-000006
ABBOTT LABORATORIES · ABT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Kevin T Conroy
Director
Period of report
Jun 30, 2026
Accepted (ET)
Jul 1, 2026 · 5:28 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0000001800
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Equivalent UnitsF1 | — | Jun 30, 2026 | A | 231 | A | — | — | Common Shares | 231 | 231 | D |
Explanation of responses
- F1Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock.